Global Therapeutic Apheresis Market to Reach USD 4,285.0 Million by 2035, Driven by Advances in Portable Devices and Decentralized Care | FMI

The global therapeutic apheresis market is poised for steady growth, forecasted to reach USD 4,285.0 million by 2035, up from USD 2,922.7 million in 2025, registering a CAGR of 3.9% over the forecast period. With 2024 revenues standing at USD 2,815.7 million, the sector continues to show resilience and innovation-driven momentum, particularly in the development and deployment of portable therapeutic devices.

Therapeutic apheresis, a process that removes harmful components from blood to treat various medical conditions, has emerged as a cornerstone of modern treatment regimens across multiple specialties including neurology, nephrology, oncology, and autoimmune disorders. As the demand for more patient-centric care models increases, the market is being redefined by technologies enabling treatments beyond hospital walls.

Explore Emerging Market Insights: Request a Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-5863

Portable Devices Redefining Treatment Paradigms

A major driver of this growth trajectory is the increased adoption of compact and portable apheresis devices. These innovative systems are lightweight and user-friendly, enabling efficient treatment delivery in non-traditional settings such as outpatient clinics and even patients’ homes. The impact is particularly notable in resource-constrained and rural areas, where access to specialized hospitals and infrastructure is limited.

Portable devices have been instrumental in expanding therapeutic access, enabling chronic care patients who require frequent treatments to benefit from local or home-based procedures. This shift not only reduces the burden on healthcare facilities but also enhances the quality of life for patients. Home-based apheresis options translate into improved compliance, fewer hospital visits, and better overall health outcomes, making them indispensable in the evolving healthcare landscape.

Therapeutic Apheresis in Transplant Medicine

One of the more promising applications of therapeutic apheresis is in organ transplantation, particularly kidney transplants. Antibody-mediated rejection remains a formidable post-operative complication, but apheresis has shown strong potential in managing and mitigating this immune response.

By effectively removing donor-specific antibodies (DSAs) and other harmful immune elements from circulation, therapeutic apheresis facilitates better graft survival and patient outcomes. This growing utilization highlights a paradigm shift toward personalized medicine, where therapies are tailored for optimal outcomes and minimal complications.

Key Takeaways

• India is projected to witness the fastest growth among major countries, with a CAGR of 4.4% between 2025 and 2035, followed by China (4.0%) and South Korea (3.8%).
• The United States and Germany will also demonstrate steady growth, with CAGRs of 3.7% and 3.6%, respectively.
• Therapeutic Plasma Exchange (TPE) will dominate the market by procedure type, accounting for a 41.3% value share in 2025.
• Hospitals will remain the leading end-user segment, capturing 47.8% of the market value in 2025.

High Demand for Market Insights: Discover Comprehensive Trends in Our Full Report! https://www.futuremarketinsights.com/reports/therapeutic-apheresis-market

Competitive Landscape: Innovation Driving Accessibility

The competitive environment in the therapeutic apheresis market is characterized by rapid technological advancements, strategic partnerships, and diversification of treatment settings. Key players are heavily focused on automation, precision medicine integration, and synergy with cell and gene therapies. This has enabled greater procedural efficiency and widened treatment availability.

The rise in outpatient and home-based care solutions has further intensified the competition. Companies are prioritizing innovations that simplify the treatment process, reduce procedure time, and ensure minimal patient discomfort—all while maintaining high clinical efficacy.

Key Industry Players:

• B. Braun Melsungen AG
• Asahi Kasei Corporation
• Baxter International, Inc.
• Fresenius Medical Care (Fresenius SE & Co. KGaA)
• Terumo Corporation
• MEDICA S.P.A.
• Haemonetics Corporation
• Cerus Corporation

Recent Industry Developments

In a notable move highlighting the industry’s focus on integrated therapies, Terumo Blood and Cell Technologies established a new Global Therapy Innovations business unit in November 2024. With Veerle d’Haenens appointed as the unit head, the initiative aims to support evolving therapeutic landscapes including apheresis therapy and emerging cell and gene therapies.

Such leadership moves signify an industry-wide shift toward innovation not just in product development, but also in aligning organizational structures with futuristic treatment demands.

Discover the Latest Healthcare Trends Today! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device

Segmental Overview

By Procedure Types:

• Therapeutic Plasma Exchange (TPE)
• Red Blood Cell Exchange (RBCX)
• Cellular Depletions
• Other Procedures

By Technology:

• Centrifugation
• Membrane Filtration

By Application:

• Sickle Cell Disease
• Neurology
• Nephrology
• Familial Hypercholesterolemia
• Oncology
• Autoimmune Disease
• Graft-versus-host Disease (GVHD)
• Solid Organ Transplants

By End User:

• Hospitals
• Blood Banks
• Specialty Clinics
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• East Asia
• South Asia & Pacific
• Western Europe
• Eastern Europe
• Middle East & Africa (MEA)

Conclusion

The global therapeutic apheresis market is transforming rapidly through a blend of technology, accessibility, and personalized medicine. As patient-centric treatment models gain ground and decentralized care becomes the norm, the role of therapeutic apheresis will only expand further—offering life-saving interventions in both acute and chronic care settings.

Companies investing in smart, scalable, and user-friendly devices are set to lead this transformation. With robust growth expected through 2035, the therapeutic apheresis sector holds a promising future not just for investors and healthcare providers, but most importantly, for patients worldwide.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube